This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of upper limb, including shoulder
CD2_INSITU_SKIN_UPPERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of upper limb, including shoulder
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 720 | 327 | 393 |
| Unadjusted period prevalence (%) | 0.15 | 0.11 | 0.17 |
| Median age at first event (years) | 75.55 | 76.10 | 75.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 619
- Matched controls
- 6190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
+∞
323.0
616
*
L57.0
ICD-10 Finland
Actinic keratosis
55.2
323.0
467
326
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
43.3
297.4
390
234
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
528.5
222.6
209
6
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
50.1
218.4
265
91
TQW99
NOMESCO Finland
Other minor procedure on skin
43.6
198.8
249
94
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
95.8
174.2
188
28
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
107.7
161.5
172
22
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
28.9
159.6
223
118
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
147.1
158.2
163
15
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
646.9
157.2
149
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
137.8
127
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
10.9
129.1
290
463
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
25.1
122.3
177
97
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
1407.2
122.2
115
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
239.7
117.1
117
6
ZXC50
NOMESCO Finland
Cryotherapy
29.2
114.2
157
71
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
40.9
113.7
143
45
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
111.9
104
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
32.3
101.2
135
53
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
99.7
93
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
167.9
96.2
99
7
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
93.1
87
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
69.9
83.6
95
16
ZZR00
NOMESCO Finland
Flap of skin
94.4
81.6
89
11
S18
ICPC
Laceration/cut
5.3
81.3
433
1880
D06BB10
ATC
imiquimod; topical
15.8
81.2
138
110
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
80.0
75
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
288.1
76.3
76
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
69.1
65
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
24.3
67.5
97
47
ZXC20
NOMESCO Finland
Use of chemical agents
30.4
66.1
89
34
127
Kela drug reimbursment
Transplant complication
51.5
64.4
77
17
ZQZ00
NOMESCO Finland
Treatment of several skin areas
178.0
62.2
64
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
61.5
58
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
69.2
59.8
68
11
XQ848
NOMESCO Finland
Dermatological photography
23.8
57.6
83
40
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
289.6
53.0
53
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
540.2
51.2
50
*
Z94.0
ICD-10 Finland
Kidney transplant status
45.8
50.8
62
15
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
50.7
48
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
48.6
46
*
SPAT1153
SPAT
Removal of sutures
3.6
47.6
310
1347
L82
ICD-10 Finland
Seborrhoeic keratosis
4.6
47.1
193
555
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
28.7
44.2
60
23
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
446.8
42.7
42
*
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
446.8
42.7
42
*
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
99.2
42.4
46
5
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
435.3
41.6
41
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
70.8
40.7
46
7
B07.9
ICD-10 Finland
Verruca simplex
12.8
40.1
73
64
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
37.9
36
*
Z2221
NOMESCO Finland
Medical doctor
3.3
37.5
247
1030
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
389.6
37.4
37
*
L04AA06
ATC
mycophenolic acid; systemic
21.4
37.3
55
28
L04AD01
ATC
ciclosporin; systemic
18.7
35.6
55
32
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
46.1
35.5
43
10
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
190.7
35.1
36
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
17.3
34.0
54
34
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
33.6
32
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
43.8
33.5
41
10
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
76.1
32.2
36
5
L04AA01
ATC
[U] ciclosporin; systemic
21.1
31.8
47
24
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
31.5
30
*
A12AA04
ATC
calcium carbonate; oral
16.2
31.4
51
34
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
31.4
288
1457
ZXE00
NOMESCO Finland
One hour or less
2.8
31.3
300
1558
S77
ICPC
Malignant neoplasm of skin
168.4
31.0
32
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
168.4
31.0
32
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
9.0
30.4
66
81
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
18.1
30.2
47
28
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
162.9
29.9
31
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.3
29.6
83
149
L04AX01
ATC
azathioprine; systemic
7.8
29.5
70
99
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.7
29.4
65
82
115
Kela drug reimbursment
Breast cancer
+∞
29.4
28
*
116
Kela drug reimbursment
Prostate cancer
+∞
29.4
28
*
Z3231
NOMESCO Finland
Registered nurse
2.9
29.4
231
1050
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
46.2
29.0
35
8
ZZA50
NOMESCO Finland
Full thickness skin graft
157.3
28.9
30
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.7
28.3
68
98
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
81.6
28.0
31
*
WF002
NOMESCO Finland
Radical radiotherapy
81.6
28.0
31
*
J01DB01
ATC
cefalexin; oral
3.2
28.0
529
4003
R4110
NOMESCO Finland
Physiotherapy
2.8
27.3
220
1005
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.3
26
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
+∞
27.3
26
*
130
Kela drug reimbursment
Malignant tumour
+∞
27.3
26
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.9
27.2
59
72
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
26.2
352
2137
TQW80
NOMESCO Finland
Local dermatologic skincare
8.9
25.9
56
68
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
271.3
25.9
26
*
S29
ICPC
Skin symptom/complaint other
3.1
25.5
162
627
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
25.2
130
432
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
25.2
291
1620
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
25.2
24
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
25.2
24
*
WX002
NOMESCO Finland
Sedation and analgesia
2.8
24.2
185
806
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
24.1
23
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
48.7
23.5
28
6
E0000UV
ATC
NA
2.4
23.5
278
1548
XQ845
NOMESCO Finland
Dermatoscopy
23.2
23.2
33
15
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
23.2
152
599
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.7
23.1
189
855
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
23.0
193
886
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
67.7
23.0
26
*
TK800
NOMESCO Finland
Hemodialysis
9.7
23.0
47
52
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
22.2
185
844
S21
ICPC
Skin texture symptom/complaint
3.3
21.9
125
444
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.4
21.9
68
138
H02AB02
ATC
dexamethasone; systemic
17.1
21.6
34
21
205
Kela drug reimbursment
Chronic hypertension
2.3
21.5
305
1836
ZX120
NOMESCO Finland
Intravenous
4.2
21.4
87
234
WX110
NOMESCO Finland
Local anesthesy
2.3
21.3
407
2815
A11CC03
ATC
alfacalcidol; systemic
7.3
21.0
51
75
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
20.9
20
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
33.8
20.3
26
8
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
19.9
19
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
19.9
19
*
D06BX02
ATC
ingenol mebutate; topical
11.2
19.7
37
35
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
13.9
19.4
33
25
ZZA00
NOMESCO Finland
Split skin graft
7.8
19.0
44
60
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.9
19.0
132
532
L01BB01
ATC
NA
72.2
18.8
21
*
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
72.2
18.8
21
*
Z3226
NOMESCO Finland
Physiotherapist
2.7
18.7
150
660
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
31.1
18.5
24
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
18.3
116
440
137
Kela drug reimbursment
Uraemia requiring dialysis
15.9
18.1
29
19
L02AE02
ATC
leuprorelin; implant, parenteral
54.2
18.1
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
17.8
17
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.8
17
*
L02BB03
ATC
bicalutamide; oral
+∞
17.8
17
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
8.4
17.8
39
49
H02AB04
ATC
methylprednisolone; systemic
2.8
17.8
131
545
ZXA05
NOMESCO Finland
Left side
2.3
17.7
217
1190
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
43.3
17.4
21
5
A98
ICPC
Health maint/preventive medicine
3.4
17.3
578
4989
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.9
17.2
39
52
ZXA00
NOMESCO Finland
Right side
2.2
16.8
224
1267
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
16.8
137
606
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
16.7
16
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
13.9
16.6
28
21
A04AA02
ATC
granisetron; systemic, transdermal
174.5
16.6
17
*
7151
FHL
Kidney transplantation
174.5
16.6
17
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
7.7
16.5
38
52
Z49.0
ICD-10 Finland
Preparatory care for dialysis
14.8
16.5
27
19
A12BA01
ATC
potassium chloride; oral
3.6
16.3
76
229
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
31.0
16.2
21
7
TQW40
NOMESCO Finland
Remowal of suture of skin
4.1
16.1
64
168
JN4BD
NOMESCO Finland
Extensive body CT
4.2
16.1
63
163
Y77
ICPC
Malignant neoplasm prostate
+∞
15.7
15
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
15.7
15
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
15.7
15
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.4
15.6
30
30
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
7.6
15.5
36
50
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
15.3
63
171
B01AB10
ATC
tinzaparin; parenteral
4.7
15.3
53
122
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.4
15.2
33
41
N18.0
ICD-10 Finland
End-stage renal disease
8.8
15.2
32
38
B03XA01
ATC
erythropoietin; parenteral
12.9
15.0
26
21
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.5
14.9
54
130
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
21.7
14.7
21
10
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
14.6
14
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
14.6
14
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
14.6
14
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
14.6
14
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
82.1
14.6
16
*
B01AB05
ATC
enoxaparin; parenteral
2.1
14.3
213
1245
C03CA01
ATC
furosemide; systemic
2.0
14.3
289
1909
D07AB08
ATC
desonide; topical
2.9
14.0
92
354
HA1AA
NOMESCO Finland
X-ray mammography
6.5
14.0
36
58
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
14.0
246
1535
JN4AD
NOMESCO Finland
Body CT examination
4.9
14.0
46
100
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
54.6
13.9
16
*
WW500
NOMESCO Finland
Blood transfusion
7.2
13.8
33
48
WF003
NOMESCO Finland
Adjuvant radiotherapy
76.9
13.6
15
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
13.6
117
528
C44
ICD-10 Finland
Other malignant neoplasms of skin
+∞
13.6
13
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
13.6
13
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
13.6
13
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
13.6
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
13.6
13
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
13.6
13
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
34.9
13.6
17
5
3AC01
NOMESCO Finland
NA
13.2
13.5
23
18
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
13.5
156
814
WZC30
NOMESCO Finland
Teaching
3.0
13.4
80
289
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
9.4
13.3
27
30
WX320
NOMESCO Finland
Spinalanesthesy
2.1
13.2
176
979
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.6
13.2
28
34
A46
ICD-10 Finland
Erysipelas
2.3
13.1
132
645
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
29.1
13.0
17
6
V03AE02
ATC
sevelamer; oral
29.1
13.0
17
6
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
23.1
13.0
18
8
A04AA01
ATC
ondansetron; systemic, rectal
6.5
12.9
33
53
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
51.1
12.9
15
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.0
12.8
31
46
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.4
12.8
21
15
S97
ICPC
Chronic ulcer skin
3.2
12.7
68
228
B05DA
ATC
Isotonic solutions
15.8
12.7
20
13
B03XA02
ATC
darbepoetin alfa; parenteral
6.9
12.7
31
47
M04AA01
ATC
allopurinol; systemic
2.3
12.6
133
662
L02BG04
ATC
letrozole; oral
71.4
12.6
14
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
12.5
12
*
L02BA01
ATC
tamoxifen; oral
+∞
12.5
12
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
132.6
12.5
13
*
C02CA01
ATC
prazosin; oral
5.4
12.5
37
72
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.4
12.2
59
184
WW200
NOMESCO Finland
Immunization
6.3
12.0
31
51
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
5.8
11.9
33
59
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
47.6
11.9
14
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
8.6
11.9
25
30
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
10.8
11.8
22
21
Z2446
NOMESCO Finland
Social worker
3.6
11.8
53
156
S82
ICPC
Naevus/mole
2.7
11.8
86
353
XX3DW
NOMESCO Finland
Time consuming IT work
4.1
11.5
45
117
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
11.5
11
*
D04
ICD-10 Finland
Carcinoma in situ of skin
122.2
11.5
12
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
11.5
532
4569
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
11.4
78
309
J01MA12
ATC
levofloxacin; systemic
2.1
11.2
136
720
N18.8
ICD-10 Finland
Other chronic renal failure
4.0
11.2
44
115
D07AC01
ATC
betamethasone; topical
1.9
11.2
235
1535
S08
ICPC
Skin colour change
3.3
11.0
55
176
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.0
10.8
34
71
S26
ICPC
Fear of cancer of skin
10.8
10.8
20
19
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
18.2
10.8
16
9
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.3
10.7
39
95
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.2
10.7
25
36
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
61.1
10.7
12
*
L12
ICPC
Hand/finger symptom/complaint
2.3
10.6
102
483
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
111.8
10.4
11
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
111.8
10.4
11
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
10.4
10
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.4
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
10.4
10
*
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
10.4
10
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
10.4
10
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
+∞
10.4
10
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
10.4
10
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
10.4
10
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.7
10.3
44
124
J01MA02
ATC
ciprofloxacin; systemic
1.8
10.3
263
1817
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
23.8
10.3
14
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
8.7
10.1
21
25
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
10.0
66
255
D05BB02
ATC
acitretin; oral
5.2
10.0
30
60
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
9.9
75
312
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
26.5
9.8
13
5
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.4
9.8
14
7
C02EA02
ATC
NA
2.8
9.6
61
231
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
9.6
50
166
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
9.6
445
3657
ZXD05
NOMESCO Finland
Urgent procedure
1.8
9.5
198
1274
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
9.5
232
1573
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.7
9.5
21
28
C08CA01
ATC
amlodipine; oral
1.7
9.5
285
2056
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
9.5
58
212
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
101.5
9.4
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
101.5
9.4
10
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
30.5
9.4
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
C44.69
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology
+∞
9.4
9
*
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
9.3
103
521
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.9
9.2
20
26
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
9.2
26
49
SPAT1211
SPAT
Application of soft bandage
2.5
9.1
73
314
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
9.1
133
753
A79
ICPC
Malignancy NOS
37.3
9.0
11
*
Z94.4
ICD-10 Finland
Liver transplant status
37.3
9.0
11
*
S99
ICPC
Skin disease other
5.6
9.0
25
46
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.1
8.9
19
24
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
12.8
8.9
15
12
E000001
ATC
NA
2.0
8.9
135
773
TQW40
SPAT
NA
4.5
8.8
30
69
SPAT1325
SPAT
Vaccination
1.7
8.8
265
1897
C08CA02
ATC
felodipine; oral
2.1
8.8
100
512
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
3.5
8.8
40
120
ZXA10
NOMESCO Finland
Bilateral
1.9
8.8
144
848
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
8.7
90
439
J05AB11
ATC
valaciclovir; oral
2.3
8.7
83
389
ZX112
NOMESCO Finland
Subcutaneous
11.8
8.6
15
13
Z49.2
ICD-10 Finland
Other dialysis
11.8
8.6
15
13
J01CA04
ATC
amoxicillin; systemic
1.7
8.6
447
3723
QCA10
NOMESCO Finland
Incision of skin of upper limb
27.9
8.5
11
*
WXQ99
NOMESCO Finland
Other light therapy
91.2
8.4
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
8.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.3
8
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
8.3
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
8.3
8
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
8.3
8
*
X76
ICPC
Malignant neoplasm breast female
+∞
8.3
8
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
8.3
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.3
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.3
8
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
8.3
144
866
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
9.6
8.3
16
17
Z71.8
ICD-10 Finland
Other specified counselling
1.9
8.3
140
833
ZXC10
NOMESCO Finland
Use of laser
5.5
8.2
23
43
EBA10
NOMESCO Finland
Surgical removal of tooth
2.8
8.2
51
189
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
8.2
43
144
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.6
8.2
35
100
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
8.2
33
90
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.9
8.1
14
12
196
Kela drug reimbursment
Paricalcitol and cinacalcet
17.4
8.1
12
7
D03.5
ICD-10 Finland
Melanoma in situ of trunk
33.8
8.1
10
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
8.0
352
2773
D02AX
ATC
Other emollients and protectives
4.2
8.0
29
72
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
7.9
278
2057
D02AE01
ATC
carbamide; topical
2.6
7.9
57
233
J01FF01
ATC
clindamycin; systemic
1.8
7.9
170
1094
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.8
263
1922
C02AC05
ATC
moxonidine; oral
2.8
7.8
49
183
J05AB01
ATC
aciclovir; systemic
1.9
7.8
123
713
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
45.6
7.7
9
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.5
7.7
26
60
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
7.6
7.7
17
23
NK6AN
NOMESCO Finland
Total body bone isotope imaging
18.6
7.6
11
6
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
7.6
81
402
S04
ICPC
Lump/swelling localized
2.5
7.6
61
263
V03AE01
ATC
polystyrene sulfonate; oral
5.5
7.6
21
39
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
7.5
71
333
C03DA01
ATC
spironolactone; oral
2.0
7.5
102
560
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
7.5
142
879
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
6.6
7.5
18
28
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.7
7.5
24
53
C07AB07
ATC
bisoprolol; oral
1.6
7.4
355
2831
Z94.1
ICD-10 Finland
Heart transplant status
81.0
7.4
8
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
81.0
7.4
8
*
R60.0
ICD-10 Finland
Localized oedema
2.0
7.3
93
497
C44.92
ICD-10 Finland
Unspecified localization of spinocellular carcinoma of the skin
+∞
7.3
7
*
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
+∞
7.3
7
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
7.3
7
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
C08CA03
ATC
isradipine; systemic
5.5
7.3
20
37
L84
ICD-10 Finland
Corns and callosities
3.4
7.3
33
100
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
7.3
64
289
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.0
7.3
27
69
40399
ICD-8 Finland
Hypertensive renal disease
16.0
7.2
11
7
V03AE03
ATC
lanthanum carbonate; oral
16.0
7.2
11
7
UJF32
NOMESCO Finland
Coloscopy
1.7
7.2
169
1110
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
7.4
7.2
16
22
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.3
7.2
34
106
XF612
NOMESCO Finland
Measurement of central venous pressure
20.3
7.1
10
5
A02BC02
ATC
pantoprazole; systemic
1.6
7.1
389
3190
RJ411
NOMESCO Finland
NA
12.2
7.1
12
10
B05DB
ATC
Hypertonic solutions
10.2
7.1
13
13
ZY010
NOMESCO Finland
Hospital outpatient
3.9
7.0
27
71
R50.9
ICD-10 Finland
Fever, unspecified
2.0
7.0
87
462
RS220
NOMESCO Finland
NA
6.4
7.0
17
27
Z51.5
ICD-10 Finland
Palliative care
3.7
7.0
29
82
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
7.0
38
132
S15
ICPC
Foreign body in skin
2.7
6.9
47
185
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
4.6
6.8
22
49
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
6.8
273
2067
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
6.8
34
111
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
6.8
100
565
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
40.5
6.8
8
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
40.5
6.8
8
*
TK820
NOMESCO Finland
Peritoneal dialysis
16.9
6.8
10
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
6.7
77
397
RS221
NOMESCO Finland
NA
7.9
6.6
14
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
6.6
56
251
B01AA03
ATC
warfarin; systemic
1.6
6.6
189
1309
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
12.4
6.6
11
9
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
12.4
6.6
11
9
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
6.6
38
136
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.6
208
1480
40199
ICD-8 Finland
Essential benign hypertension
3.7
6.6
27
76
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.2
6.6
23
56
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
70.5
6.4
7
*
5AB14
NOMESCO Finland
NA
70.5
6.4
7
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
70.5
6.4
7
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
70.5
6.4
7
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
70.5
6.4
7
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
14.5
6.4
10
7
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
14.5
6.4
10
7
L72.1
ICD-10 Finland
Trichilemmal cyst
2.7
6.4
42
164
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.3
6.4
30
94
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
5.3
6.4
18
35
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
6.4
222
1617
XKD00
NOMESCO Finland
Uroflowmetry
1.8
6.3
117
715
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.8
6.3
25
68
H05BX01
ATC
cinacalcet; oral
9.4
6.3
12
13
E000002
ATC
NA
2.2
6.3
63
304
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
6.3
68
341
H26.3
ICD-10 Finland
Drug-induced cataract
18.2
6.3
9
5
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
4.9
6.3
19
40
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
+∞
6.3
6
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
6.3
6
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
6.3
6
*
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
6.3
6
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
6.3
6
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
6.3
6
*
C44.90
ICD-10 Finland
Unspecified localization of malignant tumor of the skin without histology
+∞
6.3
6
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
6.3
6
*
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
6.3
6
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
6.3
6
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
27.0
6.2
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.1
132
844
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
6.1
110
663
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.1
188
1323
N03AX16
ATC
pregabalin; oral
1.7
6.1
136
878
J01MA14
ATC
moxifloxacin; systemic
2.2
6.1
59
279
S16
ICPC
Bruise/contusion
3.1
6.1
31
104
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
6.1
306
2423
L85.80
ICD-10 Finland
Hudhorn
10.2
6.0
11
11
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
6.0
39
151
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
327
355
16.04
296.59
2.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
590
1605
15.82
253.45
5.3
1.7
—
—
—
0
0
(4035726)
153
136
14.02
151.86
1.5
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
135
214
7.53
84.58
1.5
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
62
11.43
60.28
6.6
4.8
iu/ml
301.9
178.3
—
8
7
(42870588) Differential panel, method unspecified - Blood
364
1801
3.07
47.67
8.0
4.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
465
2656
3.12
46.66
8.8
4.8
e9/l
0.0
0.0
2.19
404
2250
(3001604) Monocytes [#/volume] in Blood
463
2642
3.11
46.47
8.8
4.8
e9/l
0.6
0.6
0.16
400
2223
(3030467) Casts [#/volume] in Urine by Automated count
346
1688
3.02
46.08
5.5
3.0
e6/l
0.5
0.5
0.06
289
1278
(36304419) Bacteria [Presence] in Urine
335
1612
3.02
45.64
5.2
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
467
2702
3.07
45.25
8.9
4.9
e9/l
2.0
1.8
0.64
403
2319
(3024561) Albumin [Mass/volume] in Serum or Plasma
453
2587
3.03
44.77
6.6
3.5
g/l
33.7
34.8
3.30
415
2359
(3013115) Eosinophils [#/volume] in Blood
469
2746
3.03
43.97
9.3
4.8
e9/l
0.2
0.2
3.61
408
2352
(3022096) Basophils/100 leukocytes in Blood
430
2404
2.96
43.89
9.3
5.0
%
0.6
0.6
0.41
402
2201
(40758558) Short blood count panel - Blood
277
1224
3.05
43.61
9.2
4.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
437
2475
2.95
43.35
9.5
5.3
%
9.2
8.9
1.21
408
2266
(3013650) Neutrophils [#/volume] in Blood by Automated count
490
2954
3.06
43.25
12.5
5.5
e9/l
4.1
4.5
2.89
429
2527
(3006504) Eosinophils/100 leukocytes in Blood
434
2468
2.91
42.38
9.3
5.1
%
2.6
2.9
2.59
401
2254
(3002030) Lymphocytes/100 leukocytes in Blood
437
2511
2.88
41.54
9.4
5.2
%
26.2
25.6
0.44
404
2286
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
72
123
6.39
41.18
4.7
2.4
mg/l
2.1
1.7
1.84
64
106
(3018010) Neutrophils/100 leukocytes in Blood
433
2489
2.86
40.91
9.0
5.1
%
58.3
59.1
0.57
402
2282
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
177
623
3.44
40.57
4.8
2.7
u/l
260.6
241.8
0.82
169
578
(3018418) pH of Serum or Plasma
342
1753
2.81
40.13
8.6
3.1
ph
7.4
7.4
0.14
64
298
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
614
4309
3.89
40.07
11.0
5.2
u/l
83.2
77.7
1.69
581
3922
(3002582) Erythrocytes [#/volume] in Urine
352
1837
2.79
39.80
5.8
3.1
e6/l
52.8
95.8
0.53
292
1412
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
393
2180
2.77
39.26
6.2
3.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
276
1303
2.81
37.40
4.1
2.4
e6/l
3.7
5.2
2.08
258
1125
(3018095) Leukocytes [#/volume] in Urine
381
2117
2.70
37.37
6.4
3.6
e6/l
68.4
121.4
0.91
300
1512
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
455
2785
2.72
36.32
11.2
4.9
mmol/l
1.2
1.2
0.44
412
2438
(3021589) Normoblasts [#/volume] in Blood
407
2368
2.65
35.87
14.6
8.6
e9/l
0.0
0.0
0.46
338
1924
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
485
3080
2.76
35.69
11.8
5.3
mmol/l
1.2
1.2
0.24
403
2594
(3012095) Magnesium [Moles/volume] in Serum or Plasma
204
838
3.00
35.55
3.5
2.3
mmol/l
0.8
0.8
4.58
189
757
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
452
2810
2.63
34.08
7.0
3.6
umol/l
12.4
12.2
0.21
434
2604
(3023368) Bacteria identified in Blood by Culture
334
1809
2.58
33.52
6.6
3.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
231
1044
2.79
33.44
4.4
2.7
e6/l
0.7
1.7
1.81
155
603
(3004789) Transferrin [Mass/volume] in Serum or Plasma
207
889
2.86
32.96
3.8
2.3
g/l
2.2
2.3
1.50
192
811
(3003458) Phosphate [Moles/volume] in Serum or Plasma
189
778
2.94
32.50
12.3
4.2
mmol/l
1.0
1.0
0.16
181
702
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
196
830
2.87
31.92
4.0
2.4
%
21.3
22.4
0.48
172
689
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
150
550
3.18
31.53
6.5
3.4
ng/l
127.3
91.8
1.99
132
468
(3031040) Bacteria [#/volume] in Urine by Automated count
555
3929
2.80
30.30
6.8
5.0
e6/l
582.2
3137.8
—
6
64
(3000991) Gas panel - Venous blood
138
517
3.07
27.72
10.8
5.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
210
993
2.57
26.96
3.8
2.3
umol/l
11.3
12.6
1.92
198
895
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
206
966
2.59
26.90
4.8
2.9
e6/l
1.2
2.7
2.63
131
527
(3042936) Bacteria identified in Isolate by Culture
183
815
2.67
26.51
2.2
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
678
5522
4.91
26.43
29.2
15.0
mg/l
28.8
26.4
1.01
598
4421
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
308
3.53
26.18
5.7
3.1
mmol/l
23.8
24.3
0.72
90
272
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
10
20.54
25.86
2.4
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
158
666
2.76
25.40
2.7
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
240
1247
2.39
24.79
4.7
2.6
mosm/kgh2o
526.2
546.5
0.92
209
1025
(3001122) Ferritin [Mass/volume] in Serum or Plasma
361
2234
2.24
24.49
3.9
2.7
ug/l
168.7
141.5
1.20
327
1990
(3026493) Urate [Moles/volume] in Serum or Plasma
276
1539
2.29
24.05
4.7
2.5
umol/l
4209.3
9754.7
1.08
242
1284
(3015377) Calcium [Moles/volume] in Serum or Plasma
331
2004
2.21
23.41
4.1
2.1
mmol/l
2.4
2.4
0.69
277
1609
(3032080) INR in Blood by Coagulation assay
406
2680
2.18
22.88
14.2
11.4
inr
1.4
1.4
0.06
106
743
(3044640) Blood type and Crossmatch panel - Blood
285
1638
2.22
22.81
3.4
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
640
5152
3.18
22.64
28.4
14.2
ml/min/173m2
63.8
70.5
11.22
558
4143
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
1263
2.29
22.39
3.3
2.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
690
5844
5.34
22.05
16.4
9.4
u/l
23.6
23.8
0.14
670
5526
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
100
354
3.12
21.91
3.2
1.3
ug/l
3.5
4.3
0.33
79
264
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
91
305
3.27
21.84
2.0
1.6
g/l
1.6
1.5
0.11
75
260
(46235355) HIV 1 and 2 tests - Meaningful Use set
110
413
2.96
21.74
1.9
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
366
2354
2.13
21.66
2.7
2.2
nmol/l
81.9
79.7
0.71
315
1999
(3013707) Erythrocyte sedimentation rate by Westergren method
559
4247
2.41
21.65
5.2
4.2
mm/h
17.4
14.0
3.63
499
3834
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
377
2456
2.12
21.52
4.6
3.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
537
4032
2.31
21.03
7.0
4.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
691
5916
5.17
20.45
34.5
18.9
mmol/l
139.2
139.7
3.70
683
5739
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
110
428
2.85
20.31
1.8
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
691
5928
5.11
20.12
35.6
19.0
mmol/l
4.0
4.0
0.83
681
5747
(3013826) Glucose [Moles/volume] in Serum or Plasma
490
3586
2.15
19.87
7.0
4.3
mmol/l
6.7
6.9
1.38
467
3364
(3007461) Platelets [#/volume] in Blood
696
6023
5.67
19.56
40.6
22.0
e9/l
231.9
237.9
1.13
681
5809
(3024731) MCV [Entitic volume]
696
6023
5.67
19.56
40.6
22.0
fl
92.5
91.9
2.64
689
5884
(3035941) MCH [Entitic mass]
696
6024
5.66
19.53
40.5
21.9
pg
30.5
30.5
0.16
689
5885
(3026361) Erythrocytes [#/volume] in Blood
696
6024
5.66
19.53
40.7
22.0
e12/l
4.3
4.4
5.59
677
5778
(3000963) Hemoglobin [Mass/volume] in Blood
696
6024
5.66
19.53
40.9
22.2
g/l
129.7
133.5
8.19
689
5886
(3010813) Leukocytes [#/volume] in Blood
696
6025
5.66
19.51
40.7
22.1
e9/l
7.1
6.9
0.54
676
5785
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
279
1673
2.09
19.30
2.6
2.3
mg/l
2.9
3.0
0.31
237
1397
(3020630) Protein [Mass/volume] in Serum or Plasma
125
537
2.61
18.98
2.4
1.6
g/l
63.2
66.6
5.22
118
470
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
222
1235
2.15
18.58
3.2
2.3
mmol/l
2.5
2.5
1.43
187
1052
(40761511) CBC panel - Blood by Automated count
668
5663
3.49
18.55
22.7
14.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
356
2359
2.01
18.45
3.3
3.2
ng/l
2553.2
1695.0
2.28
312
2036
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
110
451
2.70
18.30
3.1
2.1
u/l
32.2
32.8
0.06
93
363
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
642
5352
2.84
17.87
7.6
7.0
mmol/mol
40.6
41.5
2.02
580
4863
(3014111) Lactate [Moles/volume] in Serum or Plasma
123
542
2.53
17.65
9.3
5.2
mmol/l
1.3
1.5
2.15
115
520
(3044889) 12 lead EKG panel
530
4087
2.12
17.49
5.6
4.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
322
2094
1.97
17.28
4.1
3.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
158
798
2.26
16.61
2.4
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
656
5588
2.96
16.38
6.1
5.6
mmol/l
2.3
2.5
6.64
576
5004
(3002032) Base excess in Venous blood by calculation
138
666
2.33
16.11
5.4
2.9
mmol/l
1.4
2.1
1.04
110
532
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
121
553
2.43
15.97
3.2
2.2
umol/l
8.3
7.7
0.17
111
479
(3052851) Hemolysis interference index of Serum or Plasma
57
174
3.47
15.79
5.2
3.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
201
1142
2.05
15.50
2.4
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
200
1136
2.05
15.43
1.7
1.6
mg/l
2.5
1.5
0.72
160
888
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
208
3.22
15.41
2.7
2.5
u/ml
0.3
0.4
0.19
39
123
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
229
1371
1.98
15.20
4.4
4.2
ng/l
205.5
325.7
0.59
206
1192
(3021447) Carbon dioxide [Partial pressure] in Venous blood
137
675
2.27
15.18
5.5
2.9
kpa
5.7
5.8
0.60
129
650
(3009542) Hematocrit [Volume Fraction] of Blood
576
4681
2.15
15.17
33.5
17.1
%
38.9
38.4
0.92
380
2735
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
353
2456
1.86
14.68
2.5
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
154
808
2.15
14.56
3.4
2.1
%
1.8
1.8
0.00
138
707
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
153
802
2.15
14.50
2.3
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
64
222
3.07
14.40
2.6
1.4
g/l
0.6
0.4
0.32
59
182
(3017143) Hepatitis C virus Ab [Presence] in Serum
82
334
2.64
13.71
2.1
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
609
5122
2.23
13.69
5.1
4.7
mu/l
2.0
2.3
0.59
543
4539
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
71
4.67
13.65
1.4
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
395
2889
1.81
13.57
2.4
2.1
pmol/l
90.3
92.4
0.37
197
1466
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
84
348
2.60
13.57
2.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
104
478
2.37
13.46
2.4
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
78
313
2.67
13.43
11.5
7.1
mmol/l
24.5
24.3
0.18
70
286
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1748
1.85
13.39
1.7
1.6
nmol/l
19.9
19.9
0.00
225
1458
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
127
638
2.20
13.32
4.9
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
101
462
2.38
13.20
2.1
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
65
4.77
13.17
1.8
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
114
3.75
13.04
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
125
634
2.18
12.77
1.7
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
67
4.63
12.70
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
57
199
3.02
12.68
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
610
5180
2.16
12.63
5.0
4.3
mmol/l
1.3
1.3
1.05
535
4551
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
252
2.78
12.49
2.5
1.4
g/l
3.3
3.2
0.22
60
192
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
630
5427
2.29
12.44
5.6
4.9
mmol/l
4.3
4.4
2.75
561
4864
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
441
2.36
12.40
3.0
2.4
ml/min/173m2
52.6
58.3
0.90
45
183
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
77
4.30
12.36
1.7
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
65
4.61
12.23
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
62
4.66
11.98
1.1
1.1
u/ml
355.3
319.9
0.18
17
35
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
622
5357
2.18
11.85
5.5
4.9
mmol/l
1.4
1.4
0.12
550
4762
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
278
2.64
11.77
2.5
1.4
g/l
4.1
3.8
0.50
59
190
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
278
2.64
11.77
2.5
1.4
g/l
7.3
7.7
0.96
61
196
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
278
2.64
11.77
2.5
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
54
195
2.91
11.32
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
16
8.90
11.15
1.3
1.7
e6/l
511.8
1145.9
—
5
9
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
39
119
3.41
10.82
3.1
1.6
u/ml
39.2
71.8
0.23
32
92
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
55
206
2.81
10.79
3.3
1.4
—
1.4
—
0
21
(40768446) Kidney Pathology biopsy report
16
9
18.15
10.76
1.7
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
110
3.49
10.68
1.8
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
56
214
2.75
10.58
3.2
1.4
mg/l
35.8
38.4
0.18
46
173
(3034860) Kappa light chains.free [Mass/volume] in Serum
56
214
2.75
10.58
3.2
1.4
mg/l
79.5
48.8
0.53
46
172
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
87
3.80
10.52
1.5
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
117
3.37
10.40
1.8
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
147
851
1.91
10.30
1.9
1.3
g/l
2.7
2.9
0.14
72
470
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
43
144
3.11
10.28
1.7
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
295
2098
1.69
10.24
4.6
3.2
mg/l
278.8
187.2
0.18
221
1344
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
92
451
2.19
10.15
2.3
1.8
g/l
0.2
0.2
4.59
86
400
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
50
4.72
10.06
1.7
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
135
765
1.94
10.06
9.0
5.6
kpa
5.0
5.1
0.37
126
726
(3027801) Oxygen [Partial pressure] in Arterial blood
135
765
1.94
10.06
8.9
5.5
kpa
11.8
11.1
0.91
126
724
(40768800) Prostate Pathology biopsy report
20
39
5.25
9.88
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
294
2104
1.67
9.87
4.5
3.2
mmol/l
6.0
7.1
6.96
248
1723
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
82
3.77
9.79
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
257
1780
1.69
9.75
3.3
2.2
u/l
70.5
58.3
0.80
234
1612
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
36
5.39
9.68
1.8
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
133
761
1.92
9.60
9.0
5.6
mmol/l
0.6
1.3
1.10
103
582
(3037756) Immunofixation for Serum or Plasma
38
124
3.18
9.49
1.5
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
73
339
2.28
9.16
4.2
1.9
g/l
9.2
11.0
3.30
65
309
(3036481) Cortisol [Moles/volume] in Serum or Plasma
93
480
2.08
8.97
3.1
1.7
nmol/l
394.2
366.8
0.28
85
421
(3023520) Reticulocytes [#/volume] in Blood
111
611
1.97
8.95
3.5
2.3
e9/l
65.7
66.9
0.15
70
486
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
5
24.35
8.93
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
303
2228
1.62
8.89
5.5
4.0
mg/mmol
18.3
7.6
2.28
215
1426
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
15
8.12
8.88
1.8
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
625
5539
1.97
8.80
5.9
5.2
mmol/l
6.1
6.2
0.27
546
4897
(3021601) Nitrite [Presence] in Urine by Test strip
366
2826
1.60
8.71
7.6
5.5
estimate
0.0
0.0
0.00
80
468
(3024354) Oxygen [Partial pressure] in Venous blood
104
566
1.98
8.66
4.0
2.5
kpa
5.0
4.3
2.24
99
541
(3011412) CD3 cells [#/volume] in Blood
14
22
6.47
8.55
1.7
1.8
e9/l
1.1
0.8
—
8
11
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
82
3.51
8.29
3.1
2.3
e9/l
4.0
4.7
0.80
28
82
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
93
3.32
8.15
5.9
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
500
4194
1.63
8.15
3.7
3.7
pmol/l
15.1
15.2
0.42
430
3689
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
221
1533
1.64
8.04
3.9
2.5
u/l
30.7
35.8
1.49
209
1451
(40768795) Lymph node Pathology biopsy report
11
14
7.96
8.01
1.1
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
366
2866
1.56
7.92
5.7
4.1
estimate
0.0
0.0
0.00
79
476
(3035350) Ketones [Presence] in Urine by Test strip
361
2821
1.56
7.87
5.8
4.1
estimate
0.0
0.0
0.00
82
482
(3022145) Colonoscopy Study observation
93
505
1.97
7.77
1.5
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
25
71
3.61
7.75
1.4
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
484
1.98
7.73
7.8
2.6
mmol/l
1.2
1.2
0.24
80
409
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
86
3.35
7.73
3.9
2.6
%
57.7
60.0
0.38
28
86
(3017181) Myelocytes/100 leukocytes in Blood
81
420
2.05
7.70
5.5
3.5
%
0.7
0.8
0.20
34
88
(3024928) Oxygen saturation in Venous blood
38
142
2.77
7.53
3.5
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
385
3071
1.55
7.52
3.3
2.9
u/l
60.4
49.7
1.13
345
2748
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
276
2045
1.57
7.52
2.7
2.2
u/l
142.0
282.1
1.86
254
1900
(3021440) Promyelocytes/100 leukocytes in Blood
78
403
2.05
7.49
5.5
3.6
%
0.2
0.1
0.69
31
80
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
314
2398
1.55
7.46
5.4
4.2
ug/l
2.8
2.2
0.80
272
2122
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
121
726
1.80
7.42
3.1
3.2
ng/l
300.0
258.2
0.39
107
665
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
95
3.14
7.23
1.5
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
57
264
2.26
7.21
2.4
1.6
ug/l
4.4
1.8
0.51
52
222
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
192
1320
1.62
7.12
3.4
2.8
ug/l
0.8
0.8
0.21
138
948
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
23
5.74
7.08
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
48
208
2.40
7.07
2.7
3.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
384
2.03
7.02
5.4
3.6
%
0.0
1.2
0.50
26
73
(44790049)
21
57
3.76
6.95
2.0
1.3
—
—
—
0
0
(44806118)
21
57
3.76
6.95
2.0
1.3
—
—
—
0
0
(44790047)
21
57
3.76
6.95
2.0
1.3
—
—
—
0
0
(44790048)
21
57
3.76
6.95
2.0
1.3
—
—
—
0
0
(3015736) pH of Urine
293
2234
1.53
6.85
5.4
3.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
121
2.81
6.79
3.3
2.1
%
15.0
16.3
1.09
19
57
(3011397) Hemoglobin [Presence] in Urine by Test strip
201
1416
1.58
6.67
5.1
4.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
59
3.64
6.63
6.0
3.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
69
3.41
6.60
4.8
3.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
30
106
2.91
6.60
3.7
2.0
%
62.1
62.1
0.00
30
106
(3002179) Metamyelocytes/100 leukocytes in Blood
72
380
1.99
6.52
4.8
3.5
%
0.3
0.6
0.62
22
68
(3045142) Bone marrow Pathology biopsy report
16
37
4.40
6.52
1.3
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
56
270
2.16
6.44
3.3
1.3
g/l
1.3
1.1
0.23
50
245
(3003338) MCHC [Mass/volume]
508
4391
1.53
6.24
40.5
20.5
g/l
329.7
331.4
4.18
508
4355
(3022217) INR in Platelet poor plasma by Coagulation assay
155
1043
1.62
6.18
43.3
33.5
inr
1.7
1.5
0.49
17
139
(3000492) Spirometry study
71
384
1.94
6.01
1.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
151
1017
1.61
5.99
7.0
4.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
16
6.32
5.97
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
35
142
2.54
5.95
1.5
1.4
ug/g
265.0
286.0
0.27
23
85
(3023199) Leukocytes [#/volume] in Pleural fluid
23
75
3.13
5.81
1.5
1.4
e6/l
1847.5
1704.5
0.05
11
58
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
72
396
1.91
5.80
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
120
2.65
5.79
1.5
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
255
1941
1.49
5.78
4.4
4.0
%
23.2
24.4
0.57
121
988
(3003327) Ova and parasites identified in Stool by Light microscopy
32
126
2.61
5.78
1.7
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
21
65
3.30
5.76
4.8
3.0
%
1.4
1.6
0.08
16
46
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
15
37
4.12
5.65
1.1
1.2
u/l
10.4
12.8
0.39
15
32
(36660697) Celiac disease serology panel - Serum
66
358
1.93
5.54
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
25
4.86
5.51
5.8
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
45
212
2.20
5.51
2.9
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
61
323
1.97
5.49
13.6
7.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
62
3.29
5.48
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
147
1004
1.58
5.46
1.2
1.2
u/ml
1.3
1.6
0.10
18
254
(3037522) Nuclear Ab [Titer] in Serum
99
614
1.71
5.37
1.6
1.3
titre
460.0
550.3
0.25
18
152
(40768806) Pleura Pathology biopsy report
18
53
3.46
5.33
1.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
116
752
1.65
5.33
1.3
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
8
11.37
5.30
13.1
8.1
mmol/l
8.9
6.2
—
9
8
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
64
3.19
5.22
1.5
1.5
e6/l
141977.8
121832.2
—
6
41
(3017446) Testosterone [Moles/volume] in Serum or Plasma
53
272
2.02
5.21
2.4
2.3
nmol/l
11.0
14.7
2.38
47
233
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
35
4.06
5.19
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
35
4.06
5.19
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
35
154
2.34
5.04
1.7
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
36
3.95
5.00
1.5
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
77
2.92
4.96
1.5
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
19
61
3.17
4.94
1.5
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
131
2.43
4.88
3.4
3.5
mmol/l
2.4
2.8
0.50
21
87
(1616796) Gas panel - Central venous blood
29
120
2.48
4.77
4.0
3.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
13
33
3.99
4.73
2.0
1.2
ug/l
47.8
15.0
0.63
13
33
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
86
2.73
4.62
2.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
34
155
2.25
4.53
3.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
49
3.32
4.49
1.1
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
113
2.44
4.36
3.4
2.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
198
1506
1.43
4.29
1.7
1.6
mmol/l
1.4
1.3
0.35
167
1228
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
67
2.89
4.25
1.3
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
13
6.99
4.17
2.0
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
47
3.24
4.07
1.6
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
75
467
1.68
4.03
3.8
4.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
53
3.06
3.98
1.9
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
48
3.17
3.95
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
38
3.47
3.91
1.6
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
34
3.57
3.78
1.5
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
66
2.77
3.78
1.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
66
2.77
3.78
1.6
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
79
508
1.62
3.75
2.5
1.9
ug/g
187.7
192.6
0.03
64
387
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
50
3.04
3.70
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
67
415
1.68
3.68
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
67
2.73
3.68
1.6
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
8
12
6.73
3.68
1.5
1.3
e9/l
0.5
0.2
—
8
12
(3004119) Hemoglobin [Mass/volume] in Venous blood
72
455
1.65
3.67
4.0
2.7
g/l
124.4
127.6
0.67
67
442
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
156
2.10
3.67
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
156
2.10
3.67
1.6
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
16
5.68
3.66
1.6
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
30
3.71
3.65
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
56
2.90
3.65
1.0
1.0
g/l
1.5
1.6
0.08
16
48
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
17
5.35
3.52
1.3
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
41
3.21
3.51
1.4
1.2
u/l
87.4
49.0
—
8
27
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
314
2647
1.33
3.46
4.3
4.3
ng/l
1310.0
75.9
0.49
250
2052
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
154
2.06
3.40
1.4
1.5
iu/ml
0.1
0.2
—
6
40
(3013512) EKG study
242
1969
1.35
3.38
4.5
4.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
441
1.62
3.37
7.8
3.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
32
3.48
3.34
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
32
3.48
3.34
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
65
2.65
3.32
1.6
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
7
8.63
3.27
1.2
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
66
2.61
3.23
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
66
2.61
3.23
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
67
2.57
3.14
1.6
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
167
1.96
3.09
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
72
476
1.57
3.08
1.2
1.3
—
—
—
0
0
(4010399)
68
444
1.59
3.06
1.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
59
372
1.64
3.06
5.6
3.7
mmol/l
0.8
2.0
2.03
46
280
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
8
7.55
3.06
1.3
3.1
%
252.4
167.8
—
6
8
(3009343) pH of Capillary blood
61
388
1.63
3.06
5.5
3.8
ph
7.4
7.4
0.70
15
40
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
327
1.67
2.99
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
82
2.35
2.93
1.5
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
46
2.86
2.93
1.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
46
2.86
2.93
1.4
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
46
2.86
2.93
1.4
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
13
5.43
2.87
8.4
2.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
165
1.92
2.85
1.3
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
6
8.38
2.75
1.2
3.2
%
246.0
190.0
—
5
6
(3042733) HLA Ab [Presence] in Serum
5
6
8.38
2.75
5.8
6.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
126
2.02
2.68
1.5
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
19
4.25
2.68
2.9
4.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
36
206
1.79
2.66
5.4
2.3
g/l
0.4
0.2
0.58
21
60
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
32
3.15
2.65
2.4
1.4
g/l
0.9
0.9
—
10
32
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
177
1.85
2.64
1.6
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
61
2.49
2.63
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
80
2.28
2.62
1.1
1.1
—
—
—
0
0
(4062490)
11
38
2.92
2.59
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
7
7.18
2.55
1.2
1.0
—
—
—
0
0
(3025315) Body weight
5
7
7.18
2.55
10.6
3.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
7
7.18
2.55
1.2
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
11
5.49
2.55
1.0
1.2
%
82.8
85.2
—
6
11
(3006184) Hemoglobin [Mass/volume] in Capillary blood
26
136
1.95
2.53
3.3
2.1
g/l
117.1
132.2
2.27
21
98
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
165
1.85
2.53
1.3
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
26
3.49
2.48
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.4
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
21
3.84
2.47
1.1
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
40
2.78
2.38
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
8
6.28
2.37
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
155
1243
1.31
2.31
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
47
2.58
2.28
1.8
1.5
%
10.8
10.9
0.02
12
47
(3036071) Salmonella sp Ab [Titer] in Serum
6
13
4.64
2.27
1.3
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
109
834
1.36
2.22
1.2
1.3
iu/ml
55.9
42.8
0.22
31
268
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
197
1.71
2.16
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
30
3.02
2.15
1.8
1.2
—
—
—
0
0
(1002224) Polysomnography panel
23
123
1.90
2.13
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
185
1535
1.28
2.12
1.7
1.8
nmol/l
993.9
1182.8
2.52
135
1132
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
49
2.47
2.11
1.3
1.1
u/ml
2.7
9.3
—
6
22
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
31
2.93
2.08
1.8
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
9
31
2.93
2.08
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
20
3.52
2.06
1.6
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
50
2.42
2.03
2.3
2.6
%
72.3
53.8
—
6
32
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
50
2.42
2.03
1.3
1.1
u/ml
1.2
1.6
—
6
13
(3020891) Body temperature
43
281
1.56
2.00
5.8
4.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
250
1.59
1.97
1.6
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
27
2.98
1.94
2.0
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
182
1.68
1.88
4.0
2.4
ug/min
153.1
72.1
0.47
21
116
(3044941) Cell count panel - Synovial fluid
21
115
1.85
1.84
1.5
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
17
3.55
1.84
1.3
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
24
138
1.76
1.81
1.7
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
8
29
2.78
1.79
1.5
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
47
2.36
1.78
1.2
1.1
%
130.8
115.9
0.99
11
42
(40757494) Bilirubin.total [Moles/volume] in Blood
10
42
2.40
1.68
2.6
1.7
—
12.5
—
0
5
(3008295) Osmolality of Serum or Plasma
13
62
2.12
1.66
1.0
1.5
mosm/kgh2o
278.5
271.7
—
6
40
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
62
2.12
1.66
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
62
2.12
1.66
3.0
2.2
—
—
—
0
0
(4306422)
11
49
2.26
1.64
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
697
1.32
1.59
2.2
2.5
ug/l
4.7
6.5
1.29
76
589
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
20
3.02
1.58
2.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
73
556
1.35
1.57
6.0
3.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
27
168
1.63
1.57
1.6
1.5
e6/l
15186.0
15757.0
0.04
20
118
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
194
1.57
1.51
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
21
2.87
1.51
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
362
1.41
1.47
2.8
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
17
2.95
1.36
4.0
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
84
669
1.29
1.35
7.3
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
34
234
1.48
1.32
2.4
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
18
2.79
1.28
1.4
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
18
2.79
1.28
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
241
2158
1.18
1.25
6.9
4.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
70
1.87
1.24
2.8
2.7
—
—
—
0
0
(4268621)
8
36
2.24
1.24
1.9
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
147
1.58
1.24
2.7
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
49
2.06
1.22
1.2
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
128
0.46
1.17
1.5
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
142
1.57
1.15
1.5
1.2
—
—
—
0
0
(4094501)
22
142
1.57
1.15
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
95
1.70
1.14
1.6
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
44
328
1.36
1.13
6.4
2.5
e6/l
0.4
0.3
0.26
44
321
(3023410) Appearance of Cerebral spinal fluid
8
40
2.01
1.12
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
164
1434
1.19
1.12
6.1
3.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
88
1.72
1.12
4.8
2.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
2.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
2.2
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
21
2.39
1.09
1.4
1.0
mg/l
35.6
65.9
—
5
15
(3029937) Albumin [Presence] in Urine by Test strip
176
1555
1.17
1.06
7.3
4.3
estimate
0.0
0.0
0.00
77
455
(3035320) C reactive protein [Mass/volume] in Body fluid
7
33
2.13
1.05
2.6
2.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
53
1.90
1.01
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
48
1.89
1.00
1.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
48
1.89
1.00
3.1
2.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
31
223
1.41
1.00
4.5
4.0
mmol/l
3.9
3.9
0.23
31
205
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
23
2.18
0.98
1.0
1.2
—
24.8
—
0
5
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
36
1.95
0.97
1.3
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
52
1.74
0.92
5.4
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.01
0.87
1.8
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
371
1.29
0.86
1.7
1.6
%
1.5
1.7
1.09
42
305
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
64
1.73
0.86
1.1
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
12
189
0.63
0.82
4.7
2.9
mmol/l
1.4
1.7
1.47
12
184
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
32
1.88
0.82
2.2
1.0
—
—
—
0
0
(4024509)
8
47
1.71
0.81
1.9
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
131
1.46
0.79
1.3
1.2
—
—
—
0
0
(4015189)
0
28
0.00
0.76
0.0
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
100
871
1.17
0.74
12.3
8.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
39
1.80
0.72
1.9
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
76
1.59
0.72
1.1
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
26
1.93
0.70
3.2
2.1
u/ml
3081.0
1354.9
—
5
26
(3044290) Cell count panel - Cerebral spinal fluid
15
101
1.50
0.70
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
41
1.71
0.70
3.3
2.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
77
1.57
0.69
1.7
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
42
1.67
0.68
1.0
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
267
1.29
0.68
2.5
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
296
1.26
0.65
6.5
3.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
92
807
1.16
0.64
1.2
1.2
u/ml
6.3
15.2
1.08
22
281
(3038515) Glucose [Moles/volume] in Venous blood
12
175
0.68
0.61
4.7
3.1
mmol/l
7.2
7.9
0.74
12
169
(3022689) Creatine [Moles/volume] in Urine
0
20
0.00
0.60
0.0
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
72
1.54
0.59
1.6
1.2
nmol/l
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
219
0.72
0.58
7.6
4.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
36
1.67
0.56
1.5
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
63
1.43
0.52
1.1
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
45
379
1.20
0.52
4.5
2.7
mmol/l
24.3
25.2
1.27
40
366
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
207
1.27
0.50
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
26
207
1.27
0.50
4.5
5.2
mmol/l
1.3
1.3
0.04
20
189
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
280
1.22
0.49
2.6
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
45
1.56
0.49
1.0
1.0
—
3.0
—
0
14
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
68
1.48
0.47
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
15
0.00
0.41
0.0
1.9
—
1.2
—
0
15
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
15
0.00
0.41
0.0
1.5
—
14.4
—
0
9
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
10.0
—
0
18
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
61
1.31
0.39
1.1
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
39
337
1.17
0.37
2.4
2.9
e9/l
4.3
4.1
0.15
21
224
(3016018) Differential panel - Cerebral spinal fluid
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(4034850)
18
219
0.82
0.31
10.2
11.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
107
0.74
0.29
3.6
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
110
0.72
0.29
3.6
2.5
mmol/l
4.3
4.1
—
8
110
(3035285) Chloride [Moles/volume] in Venous blood
8
110
0.72
0.29
3.6
2.5
mmol/l
109.1
104.8
—
8
110
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
242
1.16
0.28
2.4
2.9
pmol/l
4.2
4.4
0.38
21
204
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
509
1.11
0.28
1.6
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
116
0.77
0.27
1.7
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
73
0.68
0.26
2.8
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
40
1.25
0.22
4.2
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
16
135
1.19
0.21
1.5
1.2
u/ml
2.9
3.9
—
5
23
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
12.2
—
860.6
—
0
10
(3009015) Lactate [Moles/volume] in Synovial fluid
0
10
0.00
0.21
0.0
1.0
—
8.0
—
0
5
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
13.7
—
1569.9
—
0
10
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
145
0.82
0.21
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
123
0.81
0.20
1.7
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
9.5
—
0.7
—
0
14
(1761868) Lipid panel - Serum or Plasma
150
1441
1.05
0.20
3.8
3.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
50
1.20
0.19
1.3
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
6
51
1.18
0.19
1.2
1.1
—
86.1
—
0
10
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
70
0.71
0.16
1.2
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
92
1.20
0.16
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
41
438
0.93
0.13
2.7
3.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
107
0.84
0.13
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
137
0.87
0.12
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
41
388
1.06
0.10
6.9
4.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
14
125
1.12
0.10
1.6
1.1
—
87.0
—
0
10
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
164
1.10
0.10
4.2
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
48
1.04
0.09
23.6
13.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
186
0.91
0.09
2.0
1.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
6
55
1.09
0.09
1.0
1.3
e6/l
169015.0
206911.6
—
6
36
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
123
0.89
0.08
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
131
1338
0.97
0.08
6.6
4.5
kg/l
1.0
1.0
0.72
21
225
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
67
1.05
0.08
1.3
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
71
0.84
0.07
1.8
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
99
1.11
0.06
1.1
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
84
820
1.03
0.06
5.1
5.1
%
37.8
33.7
2.33
52
513
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
158
1564
1.01
0.03
1.8
1.8
pmol/l
407.2
15563082.7
1.06
120
1253
(3008898) HLA-B27 [Presence]
10
95
1.05
0.00
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
235
0.98
0.00
1.1
1.2
iu/ml
214.3
110.4
—
5
93
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.2
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
8
87
0.92
0.00
2.3
2.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
83
0.96
0.00
1.4
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
57
0.88
0.00
1.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
4.7
—
13.4
—
0
9
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
2.8
—
1.2
—
0
6
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
83
0.96
0.00
1.6
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_UPPERLIMB_EXALLC – Carcinoma in situ of skin of upper limb, including shoulder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).